<DOC>
	<DOCNO>NCT00911989</DOCNO>
	<brief_summary>The main objective trial evaluate endoscopic visualization laparoscopic sleeve gastrectomy ( LSG ) procedure use endoscope insert transvaginally new device call Steerable Flex Trocar ( SFT ) .</brief_summary>
	<brief_title>Laparoscopic Sleeve Gastrectomy With Endoscopic Visualization</brief_title>
	<detailed_description />
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Inclusion Criteria Women enrol study : Are willing give consent comply evaluation treatment schedule ; Are 21 60 year age ( inclusive ) , post menopausal , otherwise longer expect bear child , e.g. , previous tubal ligation ; Are candidate surgical weight loss intervention ( meet ASMBS NIH criterion ) ; Have significant psychopathology could limit subject 's ability understand procedure , comply medical , surgical , and/or behavioral recommendation ; Agree refrain type elective procedure would affect body weight abdominal lipoplasty liposuction , mammoplasty , removal excess skin duration trial ; Are American Society Anesthesiologists ( ASA ) Class I , II , III ) ; Have negative pregnancy test ( woman childbearing potential ) . Exclusion Criteria Subjects exclude study follow : Previous pelvic surgery transverse Csections and/or tubal ligation ; Enlarged uterus ; Evidence pelvic malignancy screen ultrasound ; Documented history drug and/or alcohol abuse within 2 year Screening Visit ; Previous malabsorptive restrictive procedure perform treatment obesity ; Unable unwilling attend followup visit examination ; Planned predict concurrent surgical procedure ; Any medical condition precludes compliance study ; Immunocompromised result chronic oral steroid use , chemotherapeutic agent , immune deficiency disorder ; Conditions , opinion investigator , may jeopardize subject 's wellbeing and/or soundness clinical study ; History presence preexist autoimmune connective tissue disease , e.g. , systemic lupus erythematosus scleroderma ; Use prescription counter weight reduction medication supplement , participation weightloss program , change smoke habit within 8 week Screening Visit duration study participation ; Participation another clinical trial within 8 week Screening Visit duration trial ( unless previously approve investigator Sponsor ) ; Any condition precludes compliance study ( investigator discretion ) .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Weight Loss</keyword>
</DOC>